Cas no 106047-31-8 (3,2':5',3''-Terpyridine)
3,2':5',3''-Terpyridine Chemical and Physical Properties
Names and Identifiers
-
- 3,2':5',3''-Terpyridine
- SCHEMBL8935802
- 106047-31-8
-
- Inchi: 1S/C15H11N3/c1-3-12(9-16-7-1)13-5-6-15(18-11-13)14-4-2-8-17-10-14/h1-11H
- InChI Key: IMXCJUGAEIDZNS-UHFFFAOYSA-N
- SMILES: N1C=C(C=CC=1C1C=NC=CC=1)C1C=NC=CC=1
Computed Properties
- Exact Mass: 233.09543
- Monoisotopic Mass: 233.095297364g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 18
- Rotatable Bond Count: 2
- Complexity: 256
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 2
- Topological Polar Surface Area: 38.7?2
Experimental Properties
- PSA: 38.67
3,2':5',3''-Terpyridine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A029001471-250mg |
2,5-Di(pyridin-3-yl)pyridine |
106047-31-8 | 95% | 250mg |
$940.80 | 2023-09-04 | |
| Alichem | A029001471-500mg |
2,5-Di(pyridin-3-yl)pyridine |
106047-31-8 | 95% | 500mg |
$1685.00 | 2023-09-04 | |
| Alichem | A029001471-1g |
2,5-Di(pyridin-3-yl)pyridine |
106047-31-8 | 95% | 1g |
$2837.10 | 2023-09-04 |
3,2':5',3''-Terpyridine Related Literature
-
Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
-
Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
-
Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
-
Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
Additional information on 3,2':5',3''-Terpyridine
Recent Advances in the Study of 3,2':5',3''-Terpyridine (CAS: 106047-31-8) in Chemical Biology and Pharmaceutical Research
The compound 3,2':5',3''-Terpyridine (CAS: 106047-31-8) has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. As a tridentate ligand, it exhibits unique binding properties with transition metals, making it a valuable tool in the development of metallodrugs and catalytic systems. This research brief synthesizes the latest findings on this compound, highlighting its potential in therapeutic and diagnostic applications.
Recent studies have focused on the structural modifications of 3,2':5',3''-Terpyridine to enhance its binding affinity and selectivity for specific biological targets. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of this compound exhibit potent inhibitory effects on certain cancer-related enzymes, such as topoisomerase II. The study utilized molecular docking simulations and in vitro assays to validate these findings, suggesting a promising avenue for anticancer drug development.
In addition to its therapeutic potential, 3,2':5',3''-Terpyridine has been explored for its role in diagnostic imaging. A 2024 report in Chemical Communications detailed the synthesis of luminescent complexes incorporating this ligand, which showed high stability and brightness in biological environments. These complexes were successfully used for real-time imaging of cellular processes, offering a non-invasive tool for studying disease mechanisms.
Another area of active research involves the use of 3,2':5',3''-Terpyridine in nanotechnology. Researchers have leveraged its ability to form stable coordination polymers for the development of drug delivery systems. A recent study in ACS Nano highlighted the use of these polymers to encapsulate and release chemotherapeutic agents in a controlled manner, minimizing off-target effects and improving treatment efficacy.
Despite these advancements, challenges remain in optimizing the pharmacokinetic properties of 3,2':5',3''-Terpyridine-based compounds. Issues such as solubility and bioavailability need to be addressed to facilitate their transition from bench to bedside. Ongoing research is exploring various formulation strategies, including nanoparticle encapsulation and prodrug approaches, to overcome these limitations.
In conclusion, 3,2':5',3''-Terpyridine (CAS: 106047-31-8) continues to be a molecule of great interest in chemical biology and pharmaceutical research. Its multifunctional properties make it a versatile scaffold for drug design, diagnostic imaging, and nanotechnology applications. Future studies should focus on translating these laboratory findings into clinical applications, paving the way for innovative therapies and diagnostic tools.
106047-31-8 (3,2':5',3''-Terpyridine) Related Products
- 581-50-0(Isonicoteine)
- 27012-22-2(5-Methyl-2-phenylpyridine)
- 26844-80-4(5-Methyl-2,3'bipyridinyl)
- 15827-72-2(2,5-Diphenylpyridine)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)